These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

66 related items for PubMed ID: 6387216

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
    Lirussi F, Okolicsanyi L.
    Ital J Gastroenterol; 1992 Jan; 24(1):31-5. PubMed ID: 1571577
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bile secretory failure: recent concepts of the pathogenesis of intrahepatic cholestasis.
    Simon FR, Reichen J.
    Prog Liver Dis; 1982 Jan; 7():195-206. PubMed ID: 7051146
    [No Abstract] [Full Text] [Related]

  • 8. [Intrahepatic cholestasis caused by biochemical errors of bile acids. Part I --Nosographic, pathogenetic, diagnostic features].
    Lovisetto P, Raviolo P.
    Minerva Med; 1994 Nov; 85(11):589-96. PubMed ID: 7808683
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Bile acid synthesis.
    Salen G, Shefer S.
    Annu Rev Physiol; 1983 Nov; 45():679-85. PubMed ID: 6847167
    [No Abstract] [Full Text] [Related]

  • 11. [The bile acids in primary biliary cirrhosis. Comparison with other hepatic diseases].
    Rautureau M, Lemonnier F, Chevrel B.
    Rev Int Hepatol; 1966 Nov; 16(2):193-205. PubMed ID: 5947842
    [No Abstract] [Full Text] [Related]

  • 12. Primary bile acid kinetics in patients with primary biliary cirrhosis and in normal subjects.
    Williams CN, MacDonald IA, Park-Dincsoy H.
    Clin Invest Med; 1979 Nov; 2(1):29-40. PubMed ID: 509806
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Value of determining bile acids in the blood of patients with chronic cholestatic hepatitis and primary biliary cirrhosis].
    Radchenko VG, Mekhanik ZI.
    Vrach Delo; 1985 May; (5):26-8. PubMed ID: 4013219
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis.
    Batta AK, Salen G, Mirchandani R, Tint GS, Shefer S, Batta M, Abroon J, O'Brien CB, Senior JR.
    Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734
    [Abstract] [Full Text] [Related]

  • 17. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
    Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD.
    Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
    [Abstract] [Full Text] [Related]

  • 18. Hepatic handling of bile salts and protein in the rat during intrahepatic cholestasis.
    Goldsmith MA, Huling S, Jones AL.
    Gastroenterology; 1983 May; 84(5 Pt 1):978-86. PubMed ID: 6832571
    [Abstract] [Full Text] [Related]

  • 19. Management of the intractable cholestasis of primary biliary cirrhosis.
    Bloomer JR, Ghent CN.
    Semin Liver Dis; 1981 Nov; 1(4):345-53. PubMed ID: 7051313
    [No Abstract] [Full Text] [Related]

  • 20. Bile acids and their sulphated and glucuronidated derivatives in bile, plasma, and urine of children with intrahepatic cholestasis: effects of phenobarbital treatment.
    Stiehl A, Becker M, Czygan P, Fröhling W, Kommerell B, Rotthauwe HW, Senn M.
    Eur J Clin Invest; 1980 Aug; 10(4):307-16. PubMed ID: 6775958
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.